Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypertension, Grade 2”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02183701
What this trial is testing

Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 715
Post-approval studies (Phase 4)Study completedNCT02031861
What this trial is testing

Efficacy Study of Nifedipine Controlled-Release Tablets (Xin Ran) to Treat Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Shanghai Shyndec Pharmaceutical Co., Ltd. 38
Post-approval studies (Phase 4)Study completedNCT00130156
What this trial is testing

Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential Hypertension

Who this might be right for
High Blood Pressure
Eisai Inc. 93
Early research (Phase 1)Study completedNCT00424541
What this trial is testing

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 34
Testing effectiveness (Phase 2)Study completedNCT00710372
What this trial is testing

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Who this might be right for
Mild Essential HypertensionModerate Essential Hypertension
Cytos Biotechnology AG 83
Testing effectiveness (Phase 2)Study completedNCT00759551
What this trial is testing

Efficacy and Safety of Azilsartan in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Takeda 555
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Large-scale testing (Phase 3)Study completedNCT01631227
What this trial is testing

Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressure in Essential Hypertension

Who this might be right for
Essential Hypertension
Abbott 665
Testing effectiveness (Phase 2)Study completedNCT02322450
What this trial is testing

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Quantum Genomics SA 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808333
What this trial is testing

Nicotinamide for Retinal Protection in Primary Open-Angle Glaucoma (NADIR Trial)

Who this might be right for
Glaucoma, Open-anglePrimary Open Angle Glaucoma (POAG)
University of Chicago 96
Large-scale testing (Phase 3)Study completedNCT00250562
What this trial is testing

A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.

Who this might be right for
Hypertension
Novartis 1,171
Large-scale testing (Phase 3)Study completedNCT00344110
What this trial is testing

Study Comparing SPP100 (Aliskiren) 150mg to Placebo and to Losartan 50mg in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Hypertension
Novartis 768
Post-approval studies (Phase 4)Study completedNCT00302705
What this trial is testing

Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose

Who this might be right for
Hypertension
University of Vigo 150
Testing effectiveness (Phase 2)Study completedNCT01878201
What this trial is testing

A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 75
Not applicableStudy completedNCT02336607
What this trial is testing

The Effects on Blood Pressure Control, Pulse Wave Velocity, as Well as Safety and Tolerability of Felodipine Sustained Release in Chinese Patients.

Who this might be right for
Hypertension
AstraZeneca 529
Large-scale testing (Phase 3)Study completedNCT00856271
What this trial is testing

Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo 287
Not applicableEnded earlyNCT05583591
What this trial is testing

Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma

Who this might be right for
Open Angle Glaucoma
Diablo Eye Associates 58
Large-scale testing (Phase 3)UnknownNCT01956786
What this trial is testing

Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 540
Testing effectiveness (Phase 2)Ended earlyNCT01373086
What this trial is testing

LFF269 Compared to Placebo After Treatment in Subjects With Essential Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)UnknownNCT01848873
What this trial is testing

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Who this might be right for
Essential Hypertension
Shenzhen Ausa Pharmed Co.,Ltd 756
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation